“ЭFFICACY AND TOLERABILITY OF LENVATINIB IN RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER”. Western European Journal of Medicine and Medical Science 2, no. 6 (June 10, 2024): 11–20. Accessed November 20, 2024. https://westerneuropeanstudies.com/index.php/3/article/view/1131.